The estimated Net Worth of Vijay Kotte is at least $9.23 million dollars as of 13 November 2023. Mr. Kotte owns over 7,500 units of R1 RCM stock worth over $9,229,256 and over the last 4 years he sold RCM stock worth over $0. In addition, he makes $0 as Executive Vice President - Physician Services at R1 RCM.
Vijay has made over 3 trades of the R1 RCM stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 7,500 units of RCM stock worth $100,275 on 13 November 2023.
The largest trade he's ever made was exercising 17,615 units of R1 RCM stock on 1 October 2021 worth over $248,724. On average, Vijay trades about 3,595 units every 86 days since 2021. As of 13 November 2023 he still owns at least 653,630 units of R1 RCM stock.
You can see the complete history of Mr. Kotte stock trades at the bottom of the page.
Vijay Kotte is appointed as Executive Vice President - Physician Services of the Company. Vijay joined R1 in October 2019 and serves as Executive Vice President, Physician Services. He will be responsible for R1’s physician-focused operations, including growth, product development and strategic initiatives. Vijay joins R1 with more than 20 years of healthcare experience in consulting, operations, and developing new healthcare business ventures, including over 15 years of experience developing and managing value-based payment models for providers and payors. Most recently, he was the Chief Value Officer for DaVita Medical Group with accountability for strategy, M&A, contracting, performance and operations. Prior to that, he was the Chief Financial Officer for DaVita Medical Group with responsibility for the finance function and oversight of joint ventures. Prior to DaVita, Kotte served as President and Chief Operating Officer of Medicare operations for Meridian Health Plan. Additionally, he previously served as President of the Midwest region for WellCare Health Plans, where he was responsible for operations, sales and long-term strategic planning.
Vijay's mailing address filed with the SEC is 222 W MERCHANDISE MART PLAZA, SUITE 1750, CHICAGO, IL, 60654.
Over the last 8 years, insiders at R1 RCM have traded over $770,079,900 worth of R1 RCM stock and bought 103,238 units worth $1,376,421 . The most active insiders traders include Achi Series Lllptcp Asc Gp,..., Joseph Gerard Flanagan et John B Iii Henneman. On average, R1 RCM executives and independent directors trade stock every 27 days with the average trade being worth of $7,812,780. The most recent stock trade was executed by John M. Sparby on 6 March 2024, trading 10,046 units of RCM stock currently worth $143,959.
R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.
R1 RCM executives and other stock owners filed with the SEC include: